Literature DB >> 19963381

Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability.

Fengtian Xue1, Jianguo Fang, William W Lewis, Pavel Martásek, Linda J Roman, Richard B Silverman.   

Abstract

Recently, a series of potent and selective neuronal nitric oxide synthase inhibitors containing two basic nitrogen atoms was reported (Ji, H.; Stanton, B. Z.; Igarashi, J.; Li, H.; Martásek, P.; Roman, L. J.; Poulos, T. L.; Silverman, R. B. J. Am. Chem. Soc. 2008, 130, 3900-3914). In an effort to improve their bioavailability, three compounds (2a-c) were designed with electron-withdrawing groups near one of the basic nitrogen atoms to lower its pK(a). Inhibition studies with these compounds showed that two of them not only retained most of the potency and selectivity of the best analogue of the earlier series, but also showed improved membrane permeability based on data from a cell-based assay. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19963381      PMCID: PMC2818568          DOI: 10.1016/j.bmcl.2009.11.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  Reaction monitoring in LPOS by 19F NMR. Study of soluble polymer supports with fluorine in spacer or linker components of supports.

Authors:  Pandarinathan Lakshmipathi; Christophe Crévisy; Rene Grée
Journal:  J Comb Chem       Date:  2002 Nov-Dec

Review 2.  Nitric oxide and neurological disorders.

Authors:  Andrew J Duncan; Simon J R Heales
Journal:  Mol Aspects Med       Date:  2005-01-24

3.  Structural organization of the human neuronal nitric oxide synthase gene (NOS1).

Authors:  A V Hall; H Antoniou; Y Wang; A H Cheung; A M Arbus; S L Olson; W C Lu; C L Kau; P A Marsden
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

4.  Nitric-oxide synthase assays.

Authors:  J M Hevel; M A Marletta
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 5.  Role of nitric oxide in Parkinson's disease.

Authors:  Li Zhang; Valina L Dawson; Ted M Dawson
Journal:  Pharmacol Ther       Date:  2005-07-07       Impact factor: 12.310

6.  Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidase.

Authors:  Thomas C Rosen; Shinichi Yoshida; Roland Fröhlich; Kenneth L Kirk; Günter Haufe
Journal:  J Med Chem       Date:  2004-11-18       Impact factor: 7.446

7.  Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy.

Authors:  Haitao Ji; Sidhartha Tan; Jotaro Igarashi; Huiying Li; Matthew Derrick; Pavel Martásek; Linda J Roman; Jeannette Vásquez-Vivar; Thomas L Poulos; Richard B Silverman
Journal:  Ann Neurol       Date:  2009-02       Impact factor: 10.422

8.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

10.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

View more
  14 in total

1.  Intramolecular hydrogen bonding: a potential strategy for more bioavailable inhibitors of neuronal nitric oxide synthase.

Authors:  Kristin Jansen Labby; Fengtian Xue; James M Kraus; Haitao Ji; Jan Mataka; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-02-07       Impact factor: 3.641

2.  Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.

Authors:  Fengtian Xue; James M Kraus; Kristin Jansen Labby; Haitao Ji; Jan Mataka; Guoyao Xia; Huiying Li; Silvia L Delker; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2011-08-22       Impact factor: 7.446

3.  Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jianguo Fang; Silvia L Delker; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2011-03-16       Impact factor: 7.446

4.  Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Jinwen Huang; Haitao Ji; Jianguo Fang; Huiying Li; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2010-07-01       Impact factor: 3.641

5.  Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.

Authors:  He Huang; Haitao Ji; Huiying Li; Qing Jing; Kristin Jansen Labby; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2012-07-10       Impact factor: 15.419

6.  Peripheral but crucial: a hydrophobic pocket (Tyr(706), Leu(337), and Met(336)) for potent and selective inhibition of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Huiying Li; Jianguo Fang; Linda J Roman; Pavel Martásek; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem Lett       Date:  2010-08-26       Impact factor: 2.823

7.  Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase.

Authors:  Fengtian Xue; Huiying Li; Silvia L Delker; Jianguo Fang; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2010-10-13       Impact factor: 15.419

Review 8.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

9.  Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.

Authors:  Huiying Li; Fengtian Xue; James M Kraus; Haitao Ji; Kristin Jansen Labby; Jan Mataka; Silvia L Delker; Pavel Martásek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2012-12-22       Impact factor: 3.641

Review 10.  Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.

Authors:  He Huang; Richard B Silverman
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.